Skip to main content
TipRanks
Go Ultimate75% OFF

Valion Bio (VBIO) Ownership - Who Owns Valion Bio?

175 Followers

Valion Bio (VBIO) Ownership Overview

The ownership structure of Valion Bio (VBIO) stock is a mix of institutional, retail, and individual investors. Approximately 0.15% of the company’s stock is owned by Institutional Investors, 3.37% is owned by Insiders, and 96.48% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Apr 19, 2026Sheryle Bolton$10,400
Apr 01, 2026Valauri Christina Rizopoulos$17,860

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

VBIO top shareholders
Holder# of SharesType% HoldingValue
Jennifer Ernst32,691Insider1.52%16,411
Valauri Christina Rizopoulos19,000Insider0.88%9,538
Michael Handley11,030Insider0.51%5,537
Sheryle Bolton10,000Insider0.46%5,020
Fidelity Concord Street Trust3,152Institution0.15%1,582
Lisa G Wolf27Insider<0.01%14

Top Mutual Fund Holders

VBIO top mutual fund holders
Holder# of SharesType% HoldingValue
Fidelity Concord Street Trust3,152Institution0.15%1,582

FAQ

Who Owns Valion Bio (VBIO)?
According to the latest TipRanks data, approximately 0.15% of the company's stock is held by institutional investors, 3.37% is held by insiders, and 96.48% is held by public companies and individual investors.
What percentage of Valion Bio (VBIO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.15% of Valion Bio (VBIO) stock is held by institutional investors.
What percentage of Valion Bio (VBIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 96.48% of Valion Bio (VBIO) stock is held by public companies and individual investors.
Who owns the most shares of Valion Bio (VBIO)?
Jennifer Ernst owns the most shares of Valion Bio (VBIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.